Position in ABBV
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$19,100,189
-$824,824 QoQ
Shares Held
87,821
+0.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. ABBV ranks #2 (27.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
|
6,726 | $1,027,396 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,100,189 | 87,821 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $19,925,013 | 87,203 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $19,602,407 | 84,661 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,829,302 | 85,278 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $17,793,695 | 84,926 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $16,122,898 | 90,731 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,519,635 | 88,716 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $14,783,137 | 86,189 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $15,569,185 | 85,498 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,684,935 | 88,307 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $12,468,421 | 83,647 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $11,261,541 | 83,586 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $12,743,703 | 79,963 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $12,708,040 | 78,634 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $10,529,177 | 78,453 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $12,477,026 | 81,464 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $13,078,548 | 80,677 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $10,357,016 | 76,492 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $8,366,181 | 77,558 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $8,580,577 | 76,177 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $8,048,429 | 74,371 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $6,886,637 | 64,271 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $4,673,802 | 53,360 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $4,806,205 | 48,953 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $3,545,196 | 46,531 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||